The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of insulin-like growth factor 1 receptor (IGF1R) and amphiregulin (AREG) expressions on survival in patients with stage II/III gastric cancer enrolled in the ACTS-GC study.
Wataru Ichikawa
Honoraria - Taiho Pharmaceutical
Masanori Terashima
Honoraria - Taiho Pharmaceutical
Atsushi Ochiai
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
Koji Kitada
Research Funding - Taiho Pharmaceutical
Issei Kurahashi
Consultant or Advisory Role - Taiho Pharmaceutical
Shinichi Sakuramoto
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
Hitoshi Katai
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
Takeshi Sano
Honoraria - Taiho Pharmaceutical
Hiroshi Imamura
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
Mitsuru Sasako
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical